News

Orlando-Ophthalmologists should be aware of the risks to the ocular surface associated with long-term use of glaucoma medications, according to Robert J. Noecker, MD, MBA, who also spoke at the Cornea Health symposium during the American Academy of Ophthalmology annual meeting.

Long-term results from the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity (CRYO-ROP study) are showing continued advantages for treatment in preventing blindness and no long-term disadvantage with reference to acuity.

Pathology is the branch of medicine that deals with the nature of diseases, their cause and effect, particularly from the structural and functional changes that they cause. In its earliest forms, its origins date back to biblical times.

Asthenopia, blurred vision, and diplopia are classic symptoms of strabismus, which occasionally requires the use of prism or surgery to restore normal binocular vision. Ophthalmic prisms may be useful in the management of both tropias and phorias. In this column, we will discuss the management of prescriptions that contain prism.

Nice, France-The diffractive/refractive, fold-able, multifocal AcrySof IOL (study model MA60D3, Alcon, Fort Worth, TX) achieves similar mean distance vision and better near vision compared with the Array multifocal SA40N IOL (AMO, Santa Ana, CA), an FDA-approved IOL. Importantly, patients reported significantly fewer complaints of halos compared with the SA40N IOL, according to Philippe Dublineau, MD.

Nice, France-Microburst phacoemulsification improves surgical control and efficiency during high-vacuum/high-flow cataract surgery, resulting in a safer procedure compared with the standard phacoemulsification procedure.

Orlando-Cataract and refractive surgeons have worked hard over the last decade, perfecting their surgical techniques. Small-incision cataract surgery has revolutionized the ophthalmic profession as have developments in laser refractive procedures. But surgical technique is only part of the equation for producing outstanding surgical outcomes. Prevention of post-surgical infection is another concern.

Malm?weden-The initial results of the Early Manifest Glaucoma Trial (EMGT), a National Eye Institute-sponsored study conducted in Sweden, suggest that IOP-lowering treatment significantly delays progression of open-angle glaucoma in patients with elevated and normal IOP.

The Castillejos LASIK re-treatment spatula (Rhein Medical Inc.)was designed to help surgeons lift stubborn flaps more easily, and with less trauma to theepithelium, according to the instrument's inventor, David Castillejos, MD, FACS.

Cleveland-Cleveland Clinic's Cole Eye Institute has been chosen as the Foundation Fighting Blindness' national collection site for eyes donated for blindness research. The collection center, formally known as the Retinal Degeneration Pathophysiology Facility, was previously located in Phila-delphia.

Geneva-Visual impairment and blindness are taking a toll on poor countries in terms of lost productivity. About 80% of these cases could be prevented or treated, according to a report issued by the World Health Organization (WHO) and the International Agency for the Prevention of Blindness (IAPB).

Orlando-Abdullah Abdullah, MD, the foreign minister of the transitional government of Afghanistan, asked members of the American Academy of Ophthalmology (AAO) to help his country in any way they could to improve the state of eye care for 22 million people.

Cincinnati, OH-The quarterly Video Journal of Cataract and Refractive Surgery has published two more issues in 2002 that are available free to residency programs in the United States and surgeons abroad.

FDA Briefs

Nidek gains approval for operating system, eye-tracking deviceThe FDA has approved Nidek Inc.'s Windows-based operating system and new intraoperative eye-tracking device for the Nidek EC-5000 excimer laser system. The laser system is approved for commercial distribution in the United States for LASIK and PRK for myopia with or without astigmatism.

Fremont, CA-Addition Technology Inc. will double its product line in Europe since it recently received a CE marking for six new sizes of Intacs prescription inserts. The new sizes extend the availability of the inserts in both smaller increments (0.275, 0.325, 0.375, and 0.425 mm) and new sizes (0.21 and 0.23 mm).

Nice, France-An innovative ultra-thin, small-incision IOL featuring a unique optical system addresses existing limitations of IOL technology and has the potential to revolutionize cataract and phakic refractive IOL surgery, according to J. Charles Casebeer, MD, at the XX Congress of the European Society of Cat-aract and Refractive Surgeons.